Data Foundry

Medical device recalls 2024

Atellica CH Urinary/Cerebrospinal Fluid Protein — Class II medical device recall Z-3063-2024

Ongoing recall by Siemens Healthcare Diagnostics, Inc., reported 2024-09-18, distributed nationwide. The potential for biased quality control (QC) and patient results when using Atellica CH UCFP lot 130414 and A

Recall numberZ-3063-2024
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., Tarrytown, NY, United States
Recall initiated2024-07-29
Classified2024-09-06
Reported by FDA2024-09-18
DistributedNationwide (US)
Countries outside the USAE, AT, AU, BD, BE, BH, BR, CA, CH, CL, CN, CZ, DE, EE, EG, ES, FI, FR, GB, GR, HK, HR, HU, IE, IN, IT, JO, KE, KR, KW, LV, MX, MY, NL, NO, NZ, OM, PE, PH, PK, PL, PT, PY, RO, SA, SE, SG, SK, TH, TN, TR, TW, UY, ZA
UPC / GTIN / UDI-DI00630414279206
Lot numbers130414

Product

Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP); Siemens Material Number (SMN): 11097543

Reason for recall

The potential for biased quality control (QC) and patient results when using Atellica CH UCFP lot 130414 and ADVIA Chemistry UCFP lot 140 reagents.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-3063-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.